Because of its heterogenous presentation, Sjögren disease is commonly misdiagnosed, leading to delays in treatment ...
The European decision on Scholar Rock’s SMA treatment apitegromab will depend on upcoming FDA results from a U.S. plant ...
Morning Overview on MSN
The season’s first West Nile cases have already put people in the hospital
Health departments in four states have confirmed the first human West Nile virus cases of the 2026 season, and at least one ...
Some microorganisms that hold great promise for research have long lain dormant in historical collections. But only through ...
Morning Overview on MSN
A new study finds no safe level of drinking, tying one daily drink to cancer and heart disease
A peer-reviewed risk analysis published in the Journal of Studies on Alcohol and Drugs has found no protective effect from ...
Artificial intelligence is moving from the margins of virology into its operational core. It can scan viral genomes, ...
Australian researchers have found a new biomarker for multiple myeloma that could help doctors rapidly identify patients at ...
Background/Aims Retinopathy of prematurity (ROP) zone classification guides disease severity assessment and Early Treatment ...
Researchers at MD Anderson Cancer Center have used spatial transcriptomics to chart the internal architecture of ...
Objective To apply large language models (LLMs) to Reddit posts referencing SLE to identify patient-expressed unmet medical ...
Autoantibodies are central to the diagnosis, classification, and stratification of many autoimmune diseases, particularly ...
Scholar Rock said on Monday a European Union opinion on its experimental spinal muscular atrophy treatment could be pushed to later this year, as regulators await the U.S. FDA's classification of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results